Target intelligence / Profile preview

Cytokines and neurotrophic factors

Molecular classification
Signaling molecule, Protein family, Growth factor, Cytokine, Neurotrophin
01

Overview

Cytokines and neurotrophic factors are broad classes of signaling proteins that regulate a wide array of physiological processes. Cytokines, which include interleukins, interferons, and tumor necrosis factors, are critical mediators of the immune system, orchestrating inflammatory responses and hematopoietic processes (Zhang & An, 2007, PMID: 17893504). Neurotrophic factors, such as nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), are essential for the survival, growth, and differentiation of neurons in both the central and peripheral nervous systems (Huang & Reichardt, 2001, PMID: 11283310). Dysregulation of these factors is linked to numerous pathologies, including autoimmune diseases, chronic pain, and neurodegenerative disorders like Alzheimer's disease. Therapeutic strategies often involve monoclonal antibodies to neutralize pro-inflammatory cytokines or the administration of recombinant factors to support neuronal health. Due to their pleiotropic effects, targeting these pathways requires high specificity to avoid significant safety concerns such as systemic immunosuppression or off-target neurological effects.

Other names
Signaling proteinsGrowth factorsImmunomodulatorsNeurotrophinsCiliary neurotrophic factors
02

Mechanism of action

Drugs targeting these factors typically act by neutralizing the ligand with monoclonal antibodies, blocking their respective receptors (antagonism), or modulating downstream signaling pathways (e.g., JAK/STAT inhibition) to either suppress pathological inflammation or promote neuronal survival.

03

Biological functions

Immune responseSignal transductionNeuronal survivalInflammationCell proliferationCell differentiationHematopoiesis
04

Disease associations

InflammationNeurodegenerative diseaseCancerAutoimmune diseaseChronic painInfection
05

Safety considerations

Increased risk of serious infectionsCytokine release syndrome (CRS)Injection site or infusion reactionsPotential for neuropathic pain or sensory changesMalignancy risk (with long-term immunosuppression)
06

Interacting drugs

6 more in the full profile.

07

Biomarkers

Interleukin-6 (IL-6) levelsTumor Necrosis Factor-alpha (TNF-α) levelsC-reactive protein (CRP)Brain-derived neurotrophic factor (BDNF) serum levelsErythrocyte sedimentation rate (ESR)

Beyond the preview

Go deeper on Cytokines and neurotrophic factors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytokines and neurotrophic factors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call